Vous êtes ici : Accueil > Laboratoires > Développement des Gonades - G. ... > Publications du LDG

Publications du LDG

Publié le 20 février 2015

​​​

  
Loss of the histone chaperone ASF1B reduces female reproductive capacity in mice.
Messiaen S, Guiard J, Aigueperse C, Fliniaux I, Tourpin S, Barroca V, Allemand I, Fouchet P, Livera G, Vernet M.
Implementation of meiosis prophase I programme requires a conserved retinoid-independent stabilizer of meiotic transcripts.
Abby E, Tourpin S, Ribeiro J, Daniel K, Messiaen S, Moison D, Guerquin J, Gaillard JC, Armengaud J, Langa F, Toth A, Martini E, Livera G.
Apoptosis of Sertoli cells after conditional ablation of murine double minute 2 (Mdm2) gene is p53-dependent and results in male sterility.
Fouchécourt S, Livera G, Messiaen S, Fumel B, Parent AS, Marine JC, Monget P.
Loss of oocytes due to conditional ablation of Murine double minute 2 (Mdm2) gene is p53-dependent and results in female sterility.
Livera G, Uzbekov R, Jarrier P, Fouchécourt S, Duquenne C, Parent AS, Marine JC, Monget P.
Meiotic onset is reliant on spatial distribution but independent of germ cell number in the mouse ovary.
Arora R, Abby E, Ross AD, Cantu AV, Kissner MD, Castro V, Ho HY, Livera G, Laird DJ.
RPA homologs and ssDNA processing during meiotic recombination.
Ribeiro J, Abby E, Livera G, Martini E.
Nuclear receptors and endocrine disruptors in fetal and neonatal testes: a gapped landscape.
Rouiller-Fabre V, Guerquin MJ, N'Tumba-Byn T, Muczynski V, Moison D, Tourpin S, Messiaen S, Habert R, Livera G.
Expression of dominant-negative thyroid hormone receptor alpha1 in Leydig and Sertoli cells demonstrates no additional defect compared with expression in Sertoli cells only.
Fumel B, Froment P, Holzenberger M, Livera G, Monget P, Fouchécourt S.
A new chapter in the bisphenol A story: bisphenol S and bisphenol F are not safe alternatives to this compound.
Eladak S, Grisin T, Moison D, Guerquin MJ, N'Tumba-Byn T, Pozzi-Gaudin S, Benachi A, Livera G, Rouiller-Fabre V, Habert R.
Concerns about the widespread use of rodent models for human risk assessments of endocrine disruptors
Habert R, Muczynski V, Grisin T, Moison D, Messiaen S, Frydman R, Benachi A, Delbes G, Lambrot R, Lehraiki A, N'Tumba-Byn T, Guerquin MJ, Levacher C, Rouiller-Fabre V, Livera G
1 - 10Suivante